Axcelis director sells 900 shares in open trade
Axcelis Technologies director Thomas St.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Axcelis Technologies director Thomas St. Dennis reported an open-market sale of 900 shares of common stock at $155.37 per share on May 22, 2026.
After this transaction he held 17,695 shares, including 1,440 shares issuable upon vesting of restricted stock units that remain subject to forfeiture.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 900 | $155.37 | $140K |
Footnotes (1)
- F1. Of the shares held after this sale on May 22, 2026, 1,440 were issuable on vesting of restricted stock units granted to the director under the 2012 Equity Incentive Plan and are subject to forfeiture.
Key Figures
Key Terms
open-market sale financial
restricted stock units financial
2012 Equity Incentive Plan financial
subject to forfeiture financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Axcelis (ACLS) director Thomas St. Dennis report?
What portion of the Axcelis (ACLS) director’s holdings are restricted stock units?
Was the Axcelis (ACLS) insider sale an open-market transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.